Lasa Supergenerics Ltd vs Sotac Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Lasa Supergenerics Ltd is ₹ 7.87 as of 05 May 15:30 . The P/E Ratio of Lasa Supergenerics Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Sotac Pharmaceuticals Ltd changed from 31.3 on March 2024 to 16.4 on March 2025 . This represents a CAGR of -27.61% over 2 years The Market Cap of Lasa Supergenerics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Sotac Pharmaceuticals Ltd changed from ₹ 133.71 crore on March 2024 to ₹ 131.22 crore on March 2025 . This represents a CAGR of -0.94% over 2 years The Revenue of Lasa Supergenerics Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Sotac Pharmaceuticals Ltd is ₹ 25.5 crore as of Jun '24 . The EBITDA of Lasa Supergenerics Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Sotac Pharmaceuticals Ltd is ₹ 2.46 crore as of Jun '24 . The Net Profit of Lasa Supergenerics Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Sotac Pharmaceuticals Ltd is ₹ 1.35 crore as of Jun '24 . The Dividend Payout of Lasa Supergenerics Ltd changed from 4.46 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Sotac Pharmaceuticals Ltd changed from 13.94 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Lasa Supergenerics Ltd

Lasa Supergenerics Limited was incorporated on March 11, 2016.
The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
The Company is a veterinary API manufacturing entity, which was acquired in April, 2012.
The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra.
It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India.

About Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of 'M/s Sotac Pharmaceuticals', pursuant to a Deed of Partnership dated October 28, 2015.
Thereafter 'M/s.
Sotac Pharmaceuticals' was converted from Partnership Firm to a Private Limited Company in the name of 'Sotac Pharmaceuticals Private Limited' dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat.
Later on, Company converted into a Public Limited Company and the name of Company was changed to 'Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad. The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis.

FAQs for the comparison of Lasa Supergenerics Ltd and Sotac Pharmaceuticals Ltd

Which company has a larger market capitalization, Lasa Supergenerics Ltd or Sotac Pharmaceuticals Ltd?

Market cap of Lasa Supergenerics Ltd is 39 Cr while Market cap of Sotac Pharmaceuticals Ltd is 117 Cr

What are the key factors driving the stock performance of Lasa Supergenerics Ltd and Sotac Pharmaceuticals Ltd?

The stock performance of Lasa Supergenerics Ltd and Sotac Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lasa Supergenerics Ltd and Sotac Pharmaceuticals Ltd?

As of May 5, 2026, the Lasa Supergenerics Ltd stock price is INR ₹7.87. On the other hand, Sotac Pharmaceuticals Ltd stock price is INR ₹106.0.

How do dividend payouts of Lasa Supergenerics Ltd and Sotac Pharmaceuticals Ltd compare?

To compare the dividend payouts of Lasa Supergenerics Ltd and Sotac Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.